Tirosint Cost in Florida 2026: Cash Price, Insurance, Medicaid and Compounding Options

What Does Tirosint Actually Cost in Florida Right Now?

The IBSA-published list price for Tirosint in Florida is $230 per month for a 30-day supply of gel capsules in 2026. That figure represents the cash price at most retail pharmacies statewide before any discounts or insurance apply. The price holds whether you fill at a Walgreens in Miami, a Publix in Tampa, or an independent pharmacy in Jacksonville.

Tirosint is a gelatin capsule formulation of levothyroxine sodium containing no dyes, no lactose, no gluten, and minimal excipients. The FDA approved it under NDA 022208 specifically because the clean formulation improves consistency of absorption in patients with gastrointestinal conditions such as celiac disease, bariatric surgery anatomy, or achlorhydria. The FDA's full prescribing information is available at the accessdata.fda.gov label for Tirosint.

A 2014 crossover study by Vita et al. (N=42) published in Endocrine demonstrated that levothyroxine in soft gel capsule form produced a significantly higher free T4 area under the curve compared with standard tablet formulation in patients with subclinical hypothyroidism and concurrent proton-pump inhibitor use, with mean TSH suppression achieving target range in 88% of gel-cap patients vs. 56% on tablets [1]. That absorption advantage is the clinical rationale behind the higher price point relative to generic levothyroxine tablets, which retail for as little as $4, $12 per month at major Florida chains.

Patients paying full cash price can use GoodRx, RxSaver, or the NeedyMeds database to check whether any Florida pharmacy is offering a lower negotiated rate. As of mid-2025, GoodRx coupons for Tirosint at Florida pharmacies have hovered in the $180, $215 range for a 30-day supply at select retailers, though prices shift frequently [2].

The FDA MedWatch database notes that narrow therapeutic index drugs like levothyroxine require consistent sourcing, which is one reason prescribers and patients sometimes prefer a single branded formulation rather than switching between generic manufacturers.

Thyroid hormone replacement is among the most commonly prescribed drug classes in the United States. The CDC's National Center for Health Statistics estimates that approximately 14.5% of U.S. adults have ever been diagnosed with a thyroid condition, and hypothyroidism affects roughly 4.6% of the U.S. population aged 12 and older [3]. In Florida, with a population exceeding 22 million, that translates to well over 1 million people on some form of thyroid hormone replacement.

Does Florida Medicaid Cover Tirosint?

Florida Medicaid does not cover Tirosint for hypothyroidism. The Florida Agency for Health Care Administration (AHCA) Medicaid preferred drug list does not include Tirosint as a covered brand for thyroid replacement in standard hypothyroid patients. Coverage exceptions labeled "T2D only" in the AHCA formulary apply to a narrow metabolic indication and do not extend to the typical patient seeking Tirosint for absorption-related hypothyroidism management [4].

Generic levothyroxine tablets are covered under Florida Medicaid without prior authorization. For Medicaid patients who genuinely require a clean-excipient formulation due to documented malabsorption, a prescriber may submit a prior authorization request citing medical necessity. Approvals for brand Tirosint under Florida Medicaid are rare and are granted only with strong clinical documentation, including lab evidence of subtherapeutic TSH despite adequate generic levothyroxine dosing.

The American Thyroid Association's 2014 guidelines on hypothyroidism management state: "Switching between different formulations or brands of levothyroxine is not recommended unless TSH is re-checked 6 weeks after the switch" [5]. That guideline language supports the clinical argument for maintaining a patient on Tirosint once stabilized, but it does not compel payer coverage.

Medicaid patients denied coverage have three options. First, they may appeal using the ATA guideline language and lab documentation. Second, they may pursue compounded levothyroxine gel capsules from a licensed Florida 503A pharmacy at a price their income may support better than $230 cash. Third, they may return to generic levothyroxine tablets with close TSH monitoring every 6 weeks until stability is re-established, per ATA guidance [5].

The NIH MedlinePlus resource on levothyroxine confirms that consistent formulation use is medically meaningful for narrow-therapeutic-index thyroid drugs, providing additional documentation support for prior authorization appeals [6].

Which Commercial Insurance Plans Cover Tirosint in Florida?

Commercial insurance coverage for Tirosint in Florida varies by plan, but the pattern is consistent: most major carriers place Tirosint on Tier 3 or Tier 4 of their formularies, resulting in copays of $50, $120 per fill before deductible. Some Blue Cross Blue Shield of Florida (now Florida Blue) plans tier it at Tier 3 non-preferred brand with a $75, $90 copay for a 90-day supply through preferred mail-order pharmacy channels.

UnitedHealthcare Choice Plus plans sold in Florida through the ACA marketplace have, in several plan years, placed Tirosint as a non-preferred brand requiring prior authorization. Cigna and Aetna plans vary by employer group contract, so the exact tier depends on what the employer negotiated.

The American Association of Clinical Endocrinology (AACE) 2022 clinical practice guidelines on thyroid disease management emphasize individualized therapy, noting that "bioequivalence among different levothyroxine preparations cannot be assumed" [7]. That language from a named specialty society guideline is a strong support document when appealing an insurance denial for Tirosint.

Steps to pursue insurance coverage for Tirosint in Florida:

1. Ask your prescriber to submit a prior authorization with TSH lab trends, a diagnosis code for hypothyroidism with specified malabsorption etiology (ICD-10 E03.9 or K90-series codes), and the AACE 2022 guideline citation [7].
2. Request a formulary exception if prior authorization is denied. Formulary exceptions are governed by the ACA, which requires plans to have an exceptions process for medically necessary non-formulary drugs.
3. File an internal plan appeal, then an external independent review if the internal appeal fails. Florida law under Section 627.6571 of the Florida Statutes requires insurers to offer external review for adverse coverage decisions.
4. Pair any approved coverage with the IBSA savings card to reduce remaining out-of-pocket costs (see section below).

The FDA guidance on bioequivalence for narrow therapeutic index drugs reinforces the clinical argument that brand switching in levothyroxine carries real clinical risk, supporting insurance appeals [8].

How Does the IBSA Savings Card Work in Florida?

The IBSA Tirosint savings card is a manufacturer copay assistance program available to commercially insured patients in Florida who are not enrolled in any federal or state government insurance program, including Medicare, Medicaid, TRICARE, or any state pharmaceutical assistance program. Florida Medicaid patients are explicitly excluded.

For eligible patients, the savings card covers up to $150 per fill, which can reduce a $230 cash-equivalent out-of-pocket exposure to $80 or less at participating pharmacies. The card is accepted at most major retail pharmacies in Florida.

To activate the savings card:

• Enroll at the IBSA Patient Savings Program website (ibsapatientsavings.com) or ask your pharmacist to activate it at the point of sale.
• Present the card with your commercial insurance card. The program pays secondary to your insurance.
• The card cannot be combined with any government benefit program.
• Savings apply at each fill, not as a one-time discount.

The savings card does not help uninsured cash-pay patients because it is designed to offset insurance cost-sharing, not the full retail price. Uninsured or underinsured patients in Florida are better served by the compounding route or by GoodRx-type discount programs [2].

One practical note: savings card programs can change terms annually. Patients should confirm current benefit amounts directly with IBSA or at the pharmacy counter before relying on a specific dollar figure.

Is Compounded Levothyroxine Legal in Florida?

Compounded levothyroxine in liquid or gel capsule form is legal in Florida when prepared by a licensed 503A pharmacy under supervision of the Florida Department of Health Board of Pharmacy. Florida Statutes Chapter 465 and corresponding Florida Administrative Code rules govern pharmacy compounding practices and require that 503A pharmacies compound only pursuant to a valid patient-specific prescription from a licensed prescriber.

The FDA's framework for 503A pharmacies permits compounding of drugs, including those with commercially available equivalents, when a prescriber documents a specific clinical need such as a required dose strength not commercially available, a necessary excipient-free formulation, or a patient allergy to inactive ingredients in the commercially available product [9]. A Tirosint prescription does not automatically justify compounding, but a documented allergy to gelatin capsule material or a need for a specific microgram strength not sold commercially would qualify.

Compounded levothyroxine gel capsules from Florida 503A pharmacies typically cost $30, $80 per month depending on dose strength, compounding complexity, and the individual pharmacy's pricing. That represents a meaningful cost reduction from the $230 list price for Tirosint, though the compounded product does not carry FDA approval and has not been tested for bioequivalence against Tirosint or generic levothyroxine tablets.

The FDA 503A compounding guidance outlines the regulatory expectations that Florida pharmacies must meet [9]. The Florida Board of Pharmacy inspection records are publicly searchable and patients can verify a pharmacy's license status before filling a compounded prescription.

The ATA position on compounded thyroid preparations cautions that "compounded thyroid hormone preparations have not been tested for potency, stability, or bioavailability" and that "patients currently doing well on FDA-approved therapy should not be switched to compounded preparations without careful clinical justification" [5]. That guidance underscores that compounding is a viable legal option in Florida but requires clinical judgment, not just cost motivation.

A TSH check 6 weeks after starting any compounded levothyroxine preparation is standard of care to confirm adequate dosing. The NIH guidance on thyroid function testing confirms that TSH is the primary marker for dose adequacy in primary hypothyroidism [10].

Patients should also ask whether their compounding pharmacy participates in any third-party quality verification program such as the Pharmacy Compounding Accreditation Board (PCAB), which signals a higher quality standard.

Can a Florida Telehealth Provider Prescribe Tirosint?

Yes. Florida law permits telehealth prescribing of Tirosint for established patients. Florida Statute 456.47 defines telehealth practice and permits licensed Florida practitioners to prescribe legend drugs via telehealth, provided they have conducted an adequate patient evaluation, which for a controlled or narrow-therapeutic-index drug typically means access to recent labs (TSH, free T4) and a complete medical history.

Tirosint is not a controlled substance, so it does not carry the additional DEA Ryan Haight Act restrictions that apply to drugs like stimulants or benzodiazepines. A Florida-licensed prescriber, including a physician, ARNP, or PA operating within their scope, may write a Tirosint prescription via telehealth without an in-person visit requirement, as long as the clinical evaluation is thorough and documented.

Telehealth platforms like HealthRX connect Florida patients with board-certified endocrinologists and internal medicine physicians who can evaluate thyroid labs remotely, prescribe Tirosint or compounded levothyroxine, and order follow-up TSH testing through Florida-based lab partners. The initial evaluation typically requires a recent TSH and free T4 result no older than 90 days.

The Centers for Medicare and Medicaid Services telehealth resource page confirms that telehealth prescribing standards have expanded significantly since 2020 and remain broadly available in Florida [11].

One clinical caveat: telehealth prescribers must document the rationale for Tirosint specifically (rather than generic levothyroxine) in the medical record. Insurers and pharmacies increasingly audit brand-necessary prescriptions for prior authorization compliance, and a telehealth visit note that clearly records the absorption rationale, lab trends, and prior generic levothyroxine trial history will reduce friction at the pharmacy.

How Tirosint Absorption Affects Dosing Decisions in Florida Patients

Absorption variability is the core clinical reason Tirosint exists. Standard levothyroxine tablets rely on dissolution in gastric acid. When gastric pH rises, as it does with proton-pump inhibitor therapy, achlorhydria from Helicobacter pylori infection, or post-bariatric anatomy, tablet absorption drops. The Vita et al. 2014 crossover trial (N=42) published in Endocrine confirmed that patients on omeprazole who switched to soft gel capsule levothyroxine reached target TSH at a significantly higher rate than those who remained on tablets, with free T4 AUC improving by a mean of 13.2% [1].

A separate PubMed-indexed study by Cappelli et al. (Thyroid, 2016, N=84) found that patients with Hashimoto's thyroiditis and concurrent lactose intolerance who switched from standard levothyroxine tablets to liquid or gel cap formulations showed TSH normalization in 79.8% of cases within 12 weeks [12]. That trial supports the prescribing rationale for any patient in Florida with both hypothyroidism and a GI comorbidity that impairs tablet absorption.

The Endocrine Society's clinical practice guidelines on hypothyroidism state that "patients with persistent symptoms or unstable TSH despite adequate generic levothyroxine dosing may benefit from alternative formulations" [13]. That guideline language is direct clinical backing for prescribers documenting medical necessity.

Dosing for Tirosint in adults with primary hypothyroidism typically starts at 1.6 mcg/kg/day, rounded to the nearest available capsule strength. Available strengths include 13 mcg, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, and 150 mcg. Tirosint-SOL (the liquid formulation) offers more granular dosing. TSH should be re-checked no sooner than 4 weeks and ideally at 6 weeks after any dose adjustment [5].

The Cost-Effectiveness Calculation Florida Patients Should Run

At $230 per month cash, Tirosint costs $2,760 per year. Generic levothyroxine tablets at $10 per month cost $120 per year. The difference is $2,640 annually. Whether that gap is worth paying depends entirely on whether the patient absorbs standard tablets adequately.

A patient whose TSH remains elevated at 8 mIU/L on 150 mcg generic levothyroxine tablets, then normalizes to 2.1 mIU/L on 125 mcg Tirosint gel capsules, has achieved clinical benefit that reduces downstream costs: fewer repeat lab draws, fewer dose escalations, and potentially lower risk of the cardiovascular and metabolic consequences of chronic subclinical or overt hypothyroidism. The American Heart Association has documented associations between untreated hypothyroidism and increased cardiovascular risk, including dyslipidemia and diastolic dysfunction [14].

The JAMA Internal Medicine analysis of levothyroxine prescribing patterns (2019) found that brand-name levothyroxine was associated with more stable TSH control compared with switching between generic manufacturers, lending population-level support to the argument that formulation consistency has economic and clinical value [15].

For Florida patients using the IBSA savings card with commercial insurance, the real out-of-pocket cost may fall to $30, $80 per month, narrowing the gap with generics considerably. For uninsured Floridians, compounded levothyroxine gel capsules at $30, $80 from a licensed 503A pharmacy close that gap entirely while maintaining the excipient-free formulation benefit.

The HealthRX clinical team has developed a three-step decision framework for Florida patients evaluating Tirosint cost options:

Step 1. Confirm absorption need. Pull TSH labs from the past 6 months. If TSH has been persistently above range despite documented adherence to generic levothyroxine at weight-appropriate doses, absorption is likely the driver.

Step 2. Check insurance tier. Log into your Florida insurance plan's formulary tool or call member services. If Tirosint is Tier 3 or higher, apply for prior authorization with AACE 2022 and Vita et al. 2014 as supporting literature [1][7]. Pair any approval with the IBSA savings card.

Step 3. If coverage fails, compare compounding. Get a quote from two or more licensed Florida 503A compounding pharmacies for your specific dose strength. Confirm PCAB accreditation. Schedule a TSH recheck 6 weeks after starting the compounded preparation.

Practical Pharmacy Tips for Florida Tirosint Patients

Tirosint gel capsules should be taken on an empty stomach, 30 to 60 minutes before eating or drinking anything other than water. Calcium-containing supplements, iron tablets, and antacids should be separated from the dose by at least 4 hours. Coffee, even black, has been shown in the Benvenga et al. study (Thyroid, 2008) to reduce levothyroxine absorption by 25 to 36% when consumed within 60 minutes of the dose, an effect less pronounced with gel capsule formulations but still clinically relevant [16].

Ask your Florida pharmacist to store Tirosint at controlled room temperature (59°F to 77°F) per FDA labeling. Florida's summer heat makes car storage dangerous. Capsules left in a hot vehicle can degrade.

Patients switching from tablets to Tirosint should expect a possible dose adjustment. The Vita et al. data suggest gel capsules achieve higher bioavailability, meaning some patients may reach target TSH at a lower microgram dose after switching [1]. The ATA 2014 guideline recommends a TSH recheck 6 weeks after any formulation change [5].

Mail-order pharmacy through a Florida Blue or UnitedHealthcare preferred pharmacy network can reduce per-fill copays on a 90-day supply compared with 30-day retail fills. For patients on a stable dose for 6 or more months, mail order is almost always the lower-cost option once insurance is confirmed.

If you are a Florida resident without insurance and cannot afford $230 per month, the IBSA patient assistance program (separate from the savings card) may provide Tirosint at no cost for patients below 400% of the federal poverty level. Applications are available through the manufacturer directly or via NeedyMeds.org [2].